KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells

Molecular Oncology

Volumn 7, Issue 3, 2013, Pages 464-474

  Mohan, Nishant ^a   Ai, Walden ^a   Chakrabarti, Mrinmay ^a   Banik, Naren L ^b   Ray, Swapan K ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apigenin; Apoptosis; Combination therapy; KLF4; Neuroblastoma

Indexed keywords

APIGENIN; CASPASE 3; CASPASE ACTIVATED DEOXYRIBONUCLEASE; GELATINASE A; KRUPPEL LIKE FACTOR 4; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER GROWTH; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; WESTERN BLOTTING;

EID: 84878116048     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.12.002     Document Type: Article

References (36)

1. Albershardt T.C., Salerni B.L., Soderquist R.S., Bates D.J., Pletnev A.A., Kisselev A.F., Eastman A. Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein Noxa. J. Biol. Chem. 2011, 286:24882-24895.
2. Alves N.L., Derks I.A., Berk E., Spijker R., van Lier R.A., Eldering E. The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 2006, 24:703-716.
3. Andersen J.L., Kornbluth S. Mcl-1 rescues a glitch in the matrix. Nat. Cell. Biol. 2012, 14:563-565.
4. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 2003, 3:203-216.
5. Budhraja A., Gao N., Zhang Z., Son Y.O., Cheng S., Wang X., Ding S., Hitron A., Chen G., Luo J., Shi X. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol. Cancer Ther. 2012, 11:132-142.
6. Chan L.P., Chou T.H., Ding H.Y., Chen P.R., Chiang F.Y., Kuo P.L., Liang C.H. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochim. Biophys. Acta 2012, 1820:1081-1091.
7. Chen X., Johns D.C., Geiman D.E., Marban E., Dang D.T., Hamlin G., Sun R., Yang V.W. Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 2001, 276:30423-30428.
8. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 2006, 58:621-681.
9. Day C.L., Smits C., Fan F.C., Lee E.F., Fairlie W.D., Hinds M.G. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J. Mol. Biol. 2008, 380:958-971.
10. Fotsis T., Pepper M.S., Aktas E., Breit S., Rasku S., Adlercreutz H., Wahala K., Montesano R., Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997, 57:2916-2921.
11. Gianelli G., Falk-Marziller J., Schiraldi O., Stetler-Stevenson W.G., Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997, 277:225-228.
12. Hadler-Olsen E., Fadnes B., Sylte I., Uhlin-Hansen L., Winberg J.O. Regulation of matrix metalloproteinase activity in health and disease. FEBS J. 2011, 278:28-45.
13. Hu W., Hofstetter W.L., Li H., Zhou Y., He Y., Pataer A., Wang L., Xie K., Swisher S.G., Fang B. Putative tumor-suppressive function of Krüppel-like factor 4 in primary lung carcinoma. Clin. Cancer Res. 2009, 15:5688-5695.
14. Karmakar S., Davis K.A., Choudhury S.R., Deeconda A., Banik N.L., Ray S.K. Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways. Biochem. Biophys. Res. Commun. 2009, 388:705-710.
15. Li Z., Zhao J., Li Q., Yang W., Song Q., Li W., Liu J. KLF4 promotes hydrogen-peroxide-induced apoptosis of chronic myeloid leukemia cells involving the Bcl-2/Bax pathway. Cell Stress Chaperones 2010, 15:905-912.
16. Maris J.M., Hogarty M.D., Bagatell R., Cohn S.L. Neuroblastoma. Lancet 2007, 369:2106-2120.
17. Maris J.M. Recent advances in neuroblastoma. N. Engl. J. Med. 2010, 362:2202-2211.
18. Matthay K.K., George R.E., Yu A.L. Promising therapeutic targets in neuroblastoma. Clin. Cancer Res. 2012, 18:2740-2753.
19. Mei Y., Du W., Yang Y., Wu M. Puma/Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1. Oncogene 2005, 24:7224-7237.
20. Mei Y., Xie C., Xie W., Tian X., Li M., Wu M. Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Neoplasia 2007, 9:871-881.
21. Mohan N., Karmakar S., Choudhury S.R., Banik N.L., Ray S.K. Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Brain Res. 2009, 1283:155-166.
22. Mohan N., Banik N.L., Ray S.K. Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neurosci. Lett. 2011, 502:24-29.
23. L bountiful neuroblastoma cells by increasing differentiation and apoptosis. Cancer Biol. Ther. 2011, 12:846-854.
24. Mohan N., Karmakar S., Banik N.L., Ray S.K. SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells. Neurochem. Res. 2011, 36:1383-1396.
25. Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise. Int. J. Oncol. 2007, 30:233-245.
26. Rowland B.D., Bernard R., Peepe D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell. Biol. 2005, 7:1074-1082.
27. Shields J.M., Christy R.J., Yang V.W. Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J. Biol. Chem. 1996, 271:20009-20017.
28. Song H., Li Y., Lee J., Schwartz A.L., Bu G. Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res. 2009, 69:879-886.
29. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
30. Wang L., Zhang Z.G., Zhang R.L., Gregg S.R., Hozeska-Solgot A., LeTourneau Y., Wang Y., Chopp M. Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J. Neurosci. 2006, 26:5996-6003.
31. Wang J., Place R.F., Huang V., Wang X., Noonan E.J., Magyar C.E., Huang J., Li L.C. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res. 2010, 70:10182-10191.
32. Wei D., Gong W., Kanai M., Schlunk C., Wang L., Yao J.C., Wu T.T., Huang S., Xie K. Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005, 65:2746-2754.
33. Xu Y., Xin Y., Diao Y., Lu C., Fu J., Luo L., Yin Z. Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One 2011, 6:29169.
34. Yoon H.S., Chen X., Yang V.W. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J. Biol. Chem. 2003, 278:2101-2105.
35. Yori J.L., Seachrist D.D., Johnson E., Lozada K.L., Abdul-Karim F.W., Chodosh L.A., Schiemann W.P., Keri R.A. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 2011, 13:601-610.
36. Yu F., Li J., Chen H., Fu J., Ray S., Huang S., Zheng H., Ai W. Krüppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011, 30:2161-2172.